OIM
BHVN icon

Oracle Investment Management’s Biohaven BHVN Stock Holding History

Oracle Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.72M Buy
772,181
+32,195
+4% +$399K 5.19% 3
2025
Q3 		$11.1M Buy
739,986
+66,820
+10% +$973K 6.94% 2
2025
Q2 		$9.5M Buy
673,166
+7,221
+1% +$129K 6.51% 2
2025
Q1 		$16M Sell
665,945
-185,825
-22% -$6.55M 8.08% 4
2024
Q4 		$31.8M Buy
851,770
+146,520
+21% +$6.84M 17.32% 2
2024
Q3 		$35.2M Buy
705,250
+4,800
+0.7% +$187K 21.12% 2
2024
Q2 		$24.3M Sell
700,450
-104,400
-13% -$4.13M 22.68% 2
2024
Q1 		$44M Buy
804,850
+88,423
+12% +$4.38M 29.25% 1
2023
Q4 		$30.7M Buy
716,427
+108,900
+18% +$3.39M 18.65% 1
2023
Q3 		$15.8M Buy
607,527
+9,754
+2% +$203K 4.85% 4
2023
Q2 		$14.3M Sell
597,773
-37,703
-6% -$649K 10.54% 3
2023
Q1 		$8.68M Buy
635,476
+28,700
+5% +$457K 8.4% 4
2022
Q4 		$8.42M Buy
606,776
+205,555
+51% +$2.9M 7.03% 4
2022
Q3 		$59.3M Buy
+401,221
New +$2.91M 33.68% 1

Other funds holding BHVN

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oracle Investment Management's BHVN Position: Q4 2025 in Review

Oracle Investment Management increased its Biohaven (BHVN) stake by 4.4% in Q4 2025, buying an estimated $399K and bringing the position to 772,181 shares worth $8.72M. The position accounts for 5.19% of the portfolio, ranked #3.

Oracle Investment Management first reported a position in BHVN in Q3 2022 and has held it in 14 quarters since. The position peaked at $59.3M in Q3 2022. 272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Oracle Investment Management held 772,181 shares of Biohaven worth $8.72M as of Q4 2025.
  • Oracle Investment Management bought 32,195 Biohaven shares in Q4 2025, an estimated $399K.
  • Biohaven made up 5.19% of Oracle Investment Management's portfolio in Q4 2025, its #3 holding.
  • Oracle Investment Management first reported a position in Biohaven in Q3 2022 and has held it in 14 quarters since.
  • Oracle Investment Management's Biohaven position peaked at $59.3M in Q3 2022.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.